High-dose, high-frequency ustekinumab therapy for patients with severe hidradenitis suppurativa
Year: 2022
Type: article
Source: British Journal of Dermatology
DOI: 10.1111/bjd.21066
Institutions: Duke University, Duke Medical Center
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4212969065
